Literature DB >> 29987145

Effect of Cumulative Intravenous Voriconazole Dose on Renal Function in Hematological Patients.

Takeo Yasu1, Takaaki Konuma2, Seiichiro Kuroda1, Satoshi Takahashi3, Arinobu Tojo3.   

Abstract

Intravenous voriconazole (VRC) is formulated by the incorporation of sulfobutylether-β-cyclodextrin (SBECD), which may accumulate to adversely affect renal function. However, the effect of long-term use of intravenous VRC on renal function is unclear. Our retrospective analysis of data confirmed that worsening of renal function was significantly associated with a cumulative dose of intravenous VRC (≥400 mg/kg), suggesting that a higher cumulative dose of intravenous VRC is a risk factor for renal dysfunction.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  cumulative dose; intravenous; renal function; sulfobutylether-β-cyclodextrin; voriconazole

Mesh：

Substances：

Year:  2018        PMID： 29987145      PMCID： PMC6125534          DOI： 10.1128/AAC.00507-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Serum C-reactive protein levels affect the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.

Authors:  Takeo Yasu; Takaaki Konuma; Seiko Kato; Yosuke Kurokawa; Satoshi Takahashi; Arinobu Tojo
Journal:  Leuk Lymphoma       Date:  2017-03-17

2.  Administration of voriconazole in patients with renal dysfunction.

Authors:  Dionissios Neofytos; Lindsey R Lombardi; Ryan K Shields; Darin Ostrander; Lindsay Warren; M Hong Nguyen; Carol B Thompson; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

3.  Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.

Authors:  Si-Hyun Kim; Jae-Cheol Kwon; Chulmin Park; Seunghoon Han; Dong-Seok Yim; Jae-Ki Choi; Sung-Yeon Cho; Hyo-Jin Lee; Sun Hee Park; Su-Mi Choi; Jung-Hyun Choi; Jin-Hong Yoo; Dong-Gun Lee; Jong-Wook Lee
Journal:  Mycoses       Date:  2016-06-21       Impact factor: 4.377

Review 4.  Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).

Authors:  David R Luke; Konrad Tomaszewski; Bharat Damle; Haran T Schlamm
Journal:  J Pharm Sci       Date:  2010-08       Impact factor: 3.534

5.  Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.

Authors:  A M L Oude Lashof; J D Sobel; M Ruhnke; P G Pappas; C Viscoli; H T Schlamm; J H Rex; B J Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

6.  Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L S Fung; Philip J O'Connell; Jeremy R Chapman; Richard D M Allen
Journal:  Transplantation       Date:  2004-08-27       Impact factor: 4.939

7.  Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function.

Authors:  F Alvarez-Lerma; A Allepuz-Palau; M P Garcia; M Angeles Leon; A Navarro; H Sanchez-Ruiz; J R Iruretagoyena; P Luque-Gomez
Journal:  J Chemother       Date:  2008-02       Impact factor: 1.714

Review 8.  Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: A systematic review.

Authors:  R Brigg Turner; Jay L Martello; Ashim Malhotra
Journal:  Int J Antimicrob Agents       Date:  2015-07-22       Impact factor: 5.283

9.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

10.  Evaluation of intravenous voriconazole in patients with compromised renal function.

Authors:  Craig M Lilly; Verna L Welch; Thomas Mayer; Paul Ranauro; Joanne Meisner; David R Luke
Journal:  BMC Infect Dis       Date:  2013-01-16       Impact factor: 3.090
View more
  4 in total

Review 1.  Candidiasis and Mechanisms of Antifungal Resistance.

Authors:  Somanon Bhattacharya; Sutthichai Sae-Tia; Bettina C Fries
Journal:  Antibiotics (Basel)       Date:  2020-06-09

2.  Resveratrol Delivery from Implanted Cyclodextrin Polymers Provides Sustained Antioxidant Effect on Implanted Neural Probes.

Authors:  Rebecca M Haley; Sean T Zuckerman; Hassan Dakhlallah; Jeffery R Capadona; Horst A von Recum; Evon S Ereifej
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

3.  A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort.

Authors:  Tyler W Ackley; Dayna McManus; Jeffrey E Topal; Brian Cicali; Sunish Shah
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

4.  Extrapolating Antifungal Animal Data to Humans - Is it reliable?

Authors:  Victoria M Stevens; Scott W Mueller; Paul M Reynolds; Robert MacLaren; Tyree H Kiser
Journal:  Curr Fungal Infect Rep       Date:  2020-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.